CFT7455, a Novel IKZF1/3 Degrader, Demonstrates Potent Anti-Tumor Activity in Models of Non-Hodgkin's Lymphoma As a Single Agent or in Combination with Clinically Approved Agents

Saved in:
Bibliographic Details
Published inBlood Vol. 140; no. Supplement 1; p. 11575
Main Authors Perino, Samantha, Kirby, R. Jason, Agafonov, Roman, Chaturvedi, Prasoon, Eron, Scott, Good, Andrew, Hart, Ashley, He, Minsheng, Lobbardi, Riadh, Phillips, Andrew J, Proia, David, Henderson, James, Thomeius, Michael, Nasveschuk, Christopher, Fisher, Stewart L, Pollock, Roy Macfarlane
Format Journal Article
LanguageEnglish
Published Elsevier Inc 15.11.2022
Online AccessGet full text
ISSN0006-4971
1528-0020
DOI10.1182/blood-2022-166541

Cover

More Information
ISSN:0006-4971
1528-0020
DOI:10.1182/blood-2022-166541